ATC Group: D07AC13 Mometasone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D07AC13 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D07 Corticosteroids, dermatological preparations
3 D07A Corticosteroids, plain
4 D07AC Corticosteroids, potent (group III)
5 D07AC13 Mometasone

Active ingredients in D07AC13

Active Ingredient Description
Mometasone

Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade.

Related product monographs

Title Information Source Document Type  
ELOCON Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ELOCON Cream, 0.1% FDA, National Drug Code (US) MPI, US: SPL/PLR
ELOCON Lotion, 0.1% FDA, National Drug Code (US) MPI, US: SPL/PLR
ELOMET Cream Health Sciences Authority (SG) MPI, Generic
MOMETASONE FUROATE Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MONOVO Cream Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Finland (FI)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.